Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]

The summary for the Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44] grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]: Purpose. This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new technologies and/or improve existing technologies for the detection and evaluation of chemical and biological carcinogens in clinical and/or environmental specimens. These technologies should be amenable to automation and high sample throughput. The ultimate goal of this initiative is to develop innovative carcinogen detection technologies to the stage of commercially viable assays.

Federal Grant Title:	Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health Education
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAS-07-240
Type of Funding:	Grant
CFDA Numbers:	93.396
CFDA Descriptions:	Cancer Biology Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Posted Date:	Mar 06, 2007
Creation Date:	Mar 06, 2007
Archive Date:	Feb 02, 2008
Total Program Funding:	$1,400,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are not eligible to apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Opt...; • Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allow...; • Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Tr...; • Advancing Cancer Control Equity Research through Transformative Solutions Coordination Cen...; • Liver Cancer Collaborative Projects with the Liver Cirrhosis Network (U01 Clinical Trial O...; • Mouse Models of Human Cancers Consortium; • Integrative Cancer Biology Programs; • Memory T Lymphocytes in Cancer Immunology (R21)
More Grants from the National Institutes of Health: • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)